BCRX vs LQDA
BioCryst Pharmaceuticals, Inc. vs Liquidia Corporation — AI-powered side-by-side comparison
BCRX
BioCryst Pharmaceuticals, Inc.
55
Watch
VS
LQDA
Liquidia Corporation
68
Buy
| Metric | BCRX | LQDA |
|---|
| AI Score |
55
|
68
|
| Price |
$10.35
|
$88.09
|
| P/E Ratio |
-7.19×
|
368.26×
|
| ROE |
-221.4%
|
-154.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
23.5%
|
91.8%
|
| Debt / Equity |
-0.90×
|
1.70×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
75.0
|
55.0
|
| Beta |
0.554
|
0.572
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for BCRX versus LQDA.
LQDA leads by 13 points.
LQDA scores 68/100 (Buy) versus BCRX at 55/100 (Watch).
BCRX Committee View
33% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 68.7% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 2.09) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Revenue growing 68.7% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Price-to-book of 13.9x prices in significant intangible value — Value
- ROE of only -328.8% -- cheap may mean cheap for a reason — Value
- Debt-to-equity of 2.09 adds balance-sheet risk to the value case — Value
LQDA Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 46.8% shows genuine earnings power backing the valuation — Value
- Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 362.9 is expensive by classic value standards — Value
- Price-to-book of 12.9x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical